Touyun Biotech Group Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was HKD 268.94 million compared to HKD 198.07 million a year ago. Basic loss per share from continuing operations was HKD 0.0958 compared to HKD 0.0706 a year ago.

Diluted loss per share from continuing operations was HKD 0.0958 compared to HKD 0.0706 a year ago.